Stroke Research and Treatment / 2017 / Article / Tab 4

Research Article

Serum Uric Acid Is Associated with Poor Outcome in Black Africans in the Acute Phase of Stroke

Table 4

Independent predictors of poor functional outcome within 3 months post stroke.

PredictorsGood outcomePoor outcomeUnadjusted OR (95% CI) valueAdjusted OR (95% CI) value

Age > 45 years185 (60.5)13 (24.1)2.063 (1.061–4.010)0.0302.306 (0.966–5.508)0.060
Male gender132 (64.1)74 (35.4)0.878 (0.571–1.352)0.555
Unemployed123 (68.0)58(32.0)0.639 (0.416–0.983)0.0411.075 (0.593–1.948)0.811
Unmarried (single)62(68.1)29 (31.9)0.731(0.441–1.210)0.222
No health insurance67 (67.7)32 (32.3)0.745 (0.457–1.214)0.236
HTN212 (61.8)131(38.2)2.884 (0.813–10.226)0.0872.860 (0.670–12.211)0.156
DM66 (59.5)45 (40.5)1.226 (0.775–1.940)0.385
Smoking40 (57.1)30 (42.9)1.341 (0.789–2.281)0.277
Alcohol95 (62.9)56 (37.1)0.990 (0.642–1.527)0.964
Dyslipidemia175 (61.4)110 (38.6)1.336 (0.778–2.294)0.293
Obesity69 (61.1)44(38.9)1.112 (0.703–1.759)0.649
METS56 (60.2)37 (39.8)1.158 (0.713–1.880)0.553
CAD/IHD16 (69.6)7 (30.4)0.723 (0.290–1.806)0.486
AFIB20 (58.8)14 (41.2)1.202 (0.585–2.467)0.616
Cardiopathy25 (69.4)11 (30.6)0.719 (0.342–1.512)0.383
Valvulopathy14(70.0)6 (30.0)0.710 (0.266–1.894)0.492
Recurrent stroke32 (45.1)39 (54.9)2.488 (1.468–4.220)0.0012.566 (1.2475.280)0.010
CKD11 (64.7)6 (35.3)0.916 (0.331–2.537)0.866
Hemorrhagic stroke63 (60.6)41 (39.4)1.141 (0.714–1,822)0.582
SBP > 140 mmHg174 (63.0)102 (37.0)0.953 (0.576–1.576)0.850
DBP > 90 mmHg142 (62.6)85 (37.4)1.026 (0.659–1.598)0.909
Hyperglycemia59 (55.1)48 (44.9)1.580 (0.996–2.506)0.0511.253 (0.670–0.670)0.480
High LDLc165 (61.1)105 (38.9)1.339 (0.808–2.219)0.257
Low HDLc129 (61.4)81 (38.6)1.149 (0.744–1.776)0.531
High TC106 (62.4)64 (37.6)1.035 (0.675–1.588)0.875
High TG45 (64.3)25 (35.7)0.823 (0.536–1.589)0.771
Hyperuricemia69 (46.6)79 (53.4)3.268 (2.093–5.104)<0.0012.482 (1.3994.404)0.002
GCS < 91 (12.5)7 (87.5)12.402 (1.509–101.943)0.0054.306 (0.439–42.263)0.210
NIHSS > 1418 (30.0)42 (70.0)5.275 (2.883–9.653)<0.0011.369 (0.657–2.854)0.402
mRS > 267 (36.4)117 (63.6)16.333 (9.114–29.269)<0.00114.639 (7.59128.232)<0.001
Complications53 (49.1)55 (50.9)2.273 (1.432–3.606)<0.0011.033 (0.552–1.936)0.919
High urea40 (50.0)40 (50.0)1.968 (1,189–3.257)0.0081.037 (0.532–2.020)0.916
High creatinine56 (58.9)39 (41.1)1.239 (0.767–2.002)0.381

METS: metabolic syndrome; AFIB: atrial fibrillation; CKD: chronic kidney disease; CAD/IHD: coronary artery/ischemic heart disease.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.